HomeNewsWorld NewsEli Lilly Is Gaining on Novo Nordisk in the Obesity Race
Despite a late start, the advantage is shifting toward the U.S. company.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.